SCHEMBL17777980

SCHEMBL17777980

Cc1ccc(Sc2ccc(N3CCNCC3)c(Sc3ccc(C)cc3C)c2)c(C)c1

nearest known ligand 0.85

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 20/20 0.85
HTR3A P46098 20/20 0.85
CYP1A2 P05177 6/20 0.72
CYP3A4 P08684 6/20 0.72
CYP2D6 P10635 6/20 0.72
CYP2C9 P11712 6/20 0.72
ADRB2 P07550 2/20 0.72
ADRB1 P08588 2/20 0.72
HRH2 P25021 2/20 0.72
HTR1B P28222 2/20 0.72
HTR2A P28223 2/20 0.72
HTR2C P28335 2/20 0.72
SLC6A4 P31645 2/20 0.72
HTR7 P34969 2/20 0.72
HRH1 P35367 2/20 0.72
HTR5A P47898 2/20 0.72
HTR6 P50406 2/20 0.72
PTGS1 P23219 1/20 0.72
PTGS2 P35354 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19058818 0.92 HTR1A (1.00) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL19235677 0.86 HTR1A (0.82) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
Vortioxetine SCHEMBL29469584 0.84 HTR1A (1.00) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
Vortioxetine SCHEMBL236115 0.84 HTR1A (1.00) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
Vortioxetine SCHEMBL15623040 0.84 HTR1A (1.00) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
Vortioxetine SCHEMBL966801 0.83 HTR1A (1.00) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
Vortioxetine SCHEMBL19717678 0.83 HTR1A (0.97) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
Vortioxetine SCHEMBL18687167 0.83 HTR1A (0.97) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
Vortioxetine SCHEMBL237653 0.83 HTR1A (0.97) HTR1AHTR3ACYP1A2CYP3A4CYP2D6
SCHEMBL28470746 0.83 HTR1A (0.97) HTR1AHTR3ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016079751-A2 A PROCESS FOR PREPARATION OF VORTIOXETINE AND POLYMORPHS THEREOF MEGAFINE PHARMA (P) LTD. (IN) 2016-05-26 WO disclosed